drugset / Trial / NCT02669121
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy of the Norovirus (NoV) GI.1/GII.4 bivalent virus-like particle vaccine against moderate or severe acute gastroenteritis (AGE) due to genotype-specific (GI.1 and GII.4) NoV strains.
Timeline
- Start
- 2016-06-14
- Primary completion
- 2018-06-16
- Completion
- 2018-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NoV GI.1/GII.4 Bivalent VLP Vaccine | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.